ÆTERNA ZENTARIS Logo (EUIPO, 04/03/2020)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark ÆTERNA ZENTARIS was filed as Figurative mark on 04/03/2020 at the European Union Intellectual Property Office.
It was registered as a trademark on 08/11/2020.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Symbol of infinity #Backgrounds, in words or numerals, divided into two, horizontally #Green #Blue
| Trademark form | Figurative mark |
| File reference | 018221797 |
| Application date | April 3, 2020 |
| Publication date | May 4, 2020 |
| Entry date | August 11, 2020 |
| Expiration date | April 3, 2030 |
Trademark owner
Weismüllerstr. 50
60314 Frankfurt
DE
60314 Frankfurt
DE
Trademark representatives
Vogelweidstraße 8
60596 Frankfurt am Main
DE
goods and services
5
Pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations administered as a radiosensitizer and used for the treatment of cancer; pharmaceutical preparations used for the treatment of urological diseases; pharmaceutical preparations used for the treatment of hormonal disorders; peptides containing pharmaceutical preparations used for hormonal and tumors treatments; pharmaceutical preparations used for the treatment of endocrine diseases; pharmaceutical preparations used for the treatment of carcinoid tumors; pharmaceutical preparations used for the treatment of haematological diseases; pharmaceutical preparations used for the treatment of age-related diseases; pharmaceutical preparations used for the treatment of ophthalmological disorders; pharmaceutical preparations used for the treatment of reproductive system disorders; pharmaceutical preparations used for the treatment of endometriosis; pharmaceutical preparations used for the treatment of uterine myoma; pharmaceutical preparations used for the treatment of non-malignant tumors; pharmaceutical preparations used for the treatment of benign prostatic hyperplasia (BPH); pharmaceutical preparations used for the treatment of tropical diseases; pharmaceutical preparations used for the treatment of infectious disease; pharmaceutical preparations used for the treatment of leishmaniasis; pharmaceutical preparations used for the treatment of obesity; pharmaceutical preparations used for the treatment of diabetes and disorders related to diabetes; pharmaceutical preparations containing cytotoxic products (conjugated or not); pharmaceutical preparations used as a tubulin inhibitor; pharmaceutical preparations based on LHRH antagonists platform; pharmaceutical preparations based on bombesin antagonist platform; pharmaceutical preparations based on inhibitors of the Akt pathway; pharmaceutical preparations based on angiogenesis inhibitors platform; pharmaceutical preparations used to induce apoptosis; pharmaceutical preparations used to stimulate growth hormone secretagogue (GHS); tumor vaccines; pharmaceutical preparations for the treatment of cardiovascular diseases; preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of gastrointestinal diseases; diagnostic agents; pharmaceutical products for the treatment of neurological disorders; pharmaceutical preparations for the treatment of nasopharyngeal disorders; antibiotics; antibacterial and fungicidal preparations; pharmaceutical preparations for the treatment of mental health; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of rheumatoid diseases; pharmaceutical preparations for contraceptives and women's health; analgesic pharmaceutical products; sedativa and pharmaceutical preparations for the treatment of psychiatric disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for palliative treatments; pharmaceutical preparations for the treatment of addictions; pharmaceutical formulations for the treatment of paediatric indications
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| May 14, 2020 | Change Representative, Registered |
ID: 11018221797